NCT01251952 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- Not reported
- Other-event reporting threshold
- 5%
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Denileukin Diftitox (Ontak) | 2 / 2 | 0 / 2 | Not reported / Not reported |
Serious adverse events
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 2
- num Events
- 1
- term
- Low BUN
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 2
- num Events
- 2
- term
- Hypophosphatemia
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 2
- num Events
- 1
- term
- Hyponatremia
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 2
- num Events
- 1
- term
- Hypokalemia
- organ System
- Respiratory, thoracic and mediastinal disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 2
- num Events
- 1
- term
- Hypoxia
- organ System
- Infections and infestations
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 2
- num Events
- 1
- term
- Febrile neutropenia
- organ System
- Infections and infestations
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 2
- num Events
- 1
- term
- Streptococcus in urine
Other reported adverse events
Complete source fields
- event Groups
- description
- Denileukin Diftitox (Ontak) administered Post Autologous Transplantation. Denileukin Diftitox (Ontak) : After receiving their stem cell transplant on Day 0, participants will receive study agent via a 30 minute infusion. Participants will also receive a 30 minute infusion of study agent on Day 21. Follow-up visits for clinical assessment, blood draws for routine clinical laboratory studies and for immuno-correlative studies will also take place on days 42, 90, 180 and 360.
- id
- EG000
- other Num Affected
- 0
- other Num At Risk
- 2
- serious Num Affected
- 2
- serious Num At Risk
- 2
- title
- Denileukin Diftitox (Ontak)
- frequency Threshold
- 5
- serious Events
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 2
- num Events
- 1
- term
- Low BUN
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 2
- num Events
- 2
- term
- Hypophosphatemia
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 2
- num Events
- 1
- term
- Hyponatremia
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 2
- num Events
- 1
- term
- Hypokalemia
- organ System
- Respiratory, thoracic and mediastinal disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 2
- num Events
- 1
- term
- Hypoxia
- organ System
- Infections and infestations
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 2
- num Events
- 1
- term
- Febrile neutropenia
- organ System
- Infections and infestations
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 2
- num Events
- 1
- term
- Streptococcus in urine
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle